HK1128308A1 - Taurine transporter gene - Google Patents

Taurine transporter gene

Info

Publication number
HK1128308A1
HK1128308A1 HK09106135.4A HK09106135A HK1128308A1 HK 1128308 A1 HK1128308 A1 HK 1128308A1 HK 09106135 A HK09106135 A HK 09106135A HK 1128308 A1 HK1128308 A1 HK 1128308A1
Authority
HK
Hong Kong
Prior art keywords
transporter gene
taurine transporter
taurine
gene
transporter
Prior art date
Application number
HK09106135.4A
Other languages
English (en)
Chinese (zh)
Inventor
久大 田淵
朋也 杉山
佐依子 田中
智史 泰中
Original Assignee
中外製藥株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中外製藥株式會社 filed Critical 中外製藥株式會社
Publication of HK1128308A1 publication Critical patent/HK1128308A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK09106135.4A 2006-04-13 2009-07-08 Taurine transporter gene HK1128308A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006110467 2006-04-13
PCT/JP2007/058049 WO2007119774A1 (fr) 2006-04-13 2007-04-12 Gène transporteur de la taurine

Publications (1)

Publication Number Publication Date
HK1128308A1 true HK1128308A1 (en) 2009-10-23

Family

ID=38609534

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09106135.4A HK1128308A1 (en) 2006-04-13 2009-07-08 Taurine transporter gene

Country Status (12)

Country Link
US (1) US9238687B2 (fr)
EP (2) EP2011880B1 (fr)
JP (2) JP4977691B2 (fr)
KR (1) KR101342172B1 (fr)
CN (1) CN101421411B (fr)
AU (1) AU2007239679B2 (fr)
CA (1) CA2649148C (fr)
DK (1) DK2011880T3 (fr)
ES (1) ES2397383T3 (fr)
HK (1) HK1128308A1 (fr)
TW (1) TWI388664B (fr)
WO (1) WO2007119774A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4977691B2 (ja) 2006-04-13 2012-07-18 中外製薬株式会社 タウリントランスポーター遺伝子
JP5635260B2 (ja) * 2007-03-15 2014-12-03 中外製薬株式会社 ポリペプチドの製造方法
WO2008136398A1 (fr) * 2007-04-26 2008-11-13 Chugai Seiyaku Kabushiki Kaisha Procédé de culture cellulaire utilisant un milieu enrichi en acide aminé
DK2186905T3 (en) 2007-08-07 2016-09-19 Chugai Pharmaceutical Co Ltd Method of Preparation of Heterogeneous Protein
BRPI0818039A2 (pt) * 2007-10-15 2014-10-14 Chugai Pharmaceutical Co Ltd Método para produzir uma célula capaz de produção de alto rendimento de heteroproteínas.
MX2010004397A (es) 2007-10-24 2010-06-01 Chugai Pharmaceutical Co Ltd Celula para uso en la produccion de proteina exogena y proceso de produccion que utiliza la celula.
US8252557B2 (en) 2008-10-28 2012-08-28 Chugai Seiyaku Kabushiki Kaisha Peptide-containing culture medium for culturing animal cell
WO2010084947A1 (fr) * 2009-01-23 2010-07-29 中外製薬株式会社 Procédé de production de polypeptide hétérologue
WO2010123014A1 (fr) * 2009-04-22 2010-10-28 中外製薬株式会社 Procédé de préparation d'une cellule capable d'une forte production de protéine hétérogène
CA2830013C (fr) * 2011-04-01 2020-01-07 Chugai Seiyaku Kabushiki Kaisha Procede de production de polypeptide recombine
KR102358375B1 (ko) 2012-10-10 2022-02-08 추가이 세이야쿠 가부시키가이샤 개변 숙주 세포의 수립 방법

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019812D0 (en) 1990-09-11 1990-10-24 Scotgen Ltd Novel antibodies for treatment and prevention of infection in animals and man
US6225115B1 (en) 1992-03-04 2001-05-01 Synaptic Pharmaceutical Corporation DNA encoding taurine and GABA transporters and uses thereof
WO1993018143A1 (fr) 1992-03-04 1993-09-16 Synaptic Pharmaceutical Corporation ADN CODANT DES TRANSPORTEURS DE TAURINE ET D'ACIDE η-AMINOBUTYRIQUE ET SES EMPLOIS
JP3630453B2 (ja) 1994-09-30 2005-03-16 中外製薬株式会社 Ｉｌ−６レセプター抗体を有効成分とする未熟型骨髄腫細胞治療剤
AU695117B2 (en) * 1994-10-06 1998-08-06 Hoechst Aktiengesellschaft Regulated genes by stimulation of chondrocytes with IL-1beta
JPH09203734A (ja) 1996-01-26 1997-08-05 Sumitomo Electric Ind Ltd 抗血清、抗体、リガンド及びそれらの検出方法
JPH1075787A (ja) 1996-09-02 1998-03-24 Asahi Chem Ind Co Ltd 変異型アラニンアミノトランスフェラーゼおよびその製造法
JPH10191984A (ja) 1997-01-09 1998-07-28 Oriental Yeast Co Ltd 活性型ヒトａｌｔの製造法
DE19855313A1 (de) 1998-12-01 2000-06-08 Degussa Verfahren zur fermentativen Herstellung von D-Pantothensäure durch Verstärkung des panD-Gens in Mikroorganismen
ATE363074T1 (de) 1999-09-14 2007-06-15 Xenoport Inc Substrate und screeningverfahren für transportproteine
US6812339B1 (en) 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
CN1636058B (zh) 2001-05-14 2011-06-08 龚大为 新型丙氨酸转氨酶及其应用方法
KR20040044433A (ko) * 2001-07-10 2004-05-28 아이덱 파마슈티칼즈 코포레이션 세포자멸사 과정의 저해 및 세포 기능의 개선
EP1441589B1 (fr) 2001-11-08 2012-05-09 Abbott Biotherapeutics Corp. Formulation pharmaceutique liquide stable d'anticorps igg
WO2003062173A2 (fr) 2002-01-18 2003-07-31 Cargill, Incorporated Alanine 2,3- aminomutase
IL152905A0 (en) 2002-11-17 2003-06-24 Univ Ramot Dopaminergic markers induction in neuronal-like cells isolated from adult human bone marrow stromal cells: implications for novel gene therapy strategy for parkinsons disease
US20050265983A1 (en) 2002-11-17 2005-12-01 Eldad Melamed Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
US20030165495A1 (en) 2003-04-01 2003-09-04 Carulli John P. Nucleic acids and polypeptides
US20050170391A1 (en) * 2004-01-30 2005-08-04 Xenoport, Inc. TAUT1 transporters expressed in blood brain barrier cells
KR100789645B1 (ko) * 2004-04-14 2007-12-27 주식회사유한양행 Ｂ형 간염바이러스의 ｓ-표면항원을 인식하는 인간화 항체및 이의 제조방법
US7919086B2 (en) 2004-07-09 2011-04-05 Chugai Seiyaku Kabushiki Kaisha Anti-glypican 3 antibody
US20070166362A1 (en) 2004-10-07 2007-07-19 Shuji Sakuma Transdermal and transmucosal preparations
JP2006110467A (ja) 2004-10-14 2006-04-27 Furukawa Co Ltd 半導体製造装置用燐分離装置
PA8672101A1 (es) 2005-04-29 2006-12-07 Centocor Inc Anticuerpos anti-il-6, composiciones, métodos y usos
US20070207152A1 (en) 2005-11-09 2007-09-06 Brophy Susan E Human BNP immunospecific antibodies
CA2634925C (fr) 2005-12-23 2015-06-23 Arcadia Biosciences, Inc. Plantes monocotyledones ayant un rendement efficace en azote
JP4977691B2 (ja) 2006-04-13 2012-07-18 中外製薬株式会社 タウリントランスポーター遺伝子
JP5635260B2 (ja) 2007-03-15 2014-12-03 中外製薬株式会社 ポリペプチドの製造方法
DK2186905T3 (en) 2007-08-07 2016-09-19 Chugai Pharmaceutical Co Ltd Method of Preparation of Heterogeneous Protein
BRPI0818039A2 (pt) 2007-10-15 2014-10-14 Chugai Pharmaceutical Co Ltd Método para produzir uma célula capaz de produção de alto rendimento de heteroproteínas.
MX2010004397A (es) 2007-10-24 2010-06-01 Chugai Pharmaceutical Co Ltd Celula para uso en la produccion de proteina exogena y proceso de produccion que utiliza la celula.
WO2010123014A1 (fr) 2009-04-22 2010-10-28 中外製薬株式会社 Procédé de préparation d'une cellule capable d'une forte production de protéine hétérogène

Also Published As

Publication number Publication date
EP2011880A1 (fr) 2009-01-07
US20090191591A1 (en) 2009-07-30
TWI388664B (zh) 2013-03-11
JP5399529B2 (ja) 2014-01-29
AU2007239679A1 (en) 2007-10-25
EP2011880A4 (fr) 2009-11-11
CN101421411B (zh) 2015-06-03
AU2007239679B2 (en) 2012-10-11
EP2011880B1 (fr) 2012-10-24
WO2007119774A1 (fr) 2007-10-25
CA2649148A1 (fr) 2007-10-25
KR101342172B1 (ko) 2013-12-20
CA2649148C (fr) 2016-08-23
ES2397383T3 (es) 2013-03-06
KR20090007276A (ko) 2009-01-16
DK2011880T3 (da) 2012-11-26
JP2012143247A (ja) 2012-08-02
JPWO2007119774A1 (ja) 2009-08-27
CN101421411A (zh) 2009-04-29
JP4977691B2 (ja) 2012-07-18
EP2228450A1 (fr) 2010-09-15
TW200806790A (en) 2008-02-01
US9238687B2 (en) 2016-01-19

Similar Documents

Publication Publication Date Title
HK1128308A1 (en) Taurine transporter gene
EP2098339A4 (fr) Mécanisme parallèle
EP2017283A4 (fr) Peptide
GB0611116D0 (en) Proteins
GB0616226D0 (en) Processes
HK1109502A1 (en) Battary can
EP2029448A4 (fr) Appareil de transport
GB2456073B (en) Purge system
GB0601976D0 (en) Proteins
GB0618127D0 (en) Biomarker
GB0620735D0 (en) Proteins
GB0603645D0 (en) Balustrading
GB0722891D0 (en) Lifejacket
GB0618748D0 (en) Peptide
EP2024516A4 (fr) Proteines de perforine-2
EP1981985A4 (fr) Procedes pour puces a adn
GB0605774D0 (en) Peptide
IL197675A0 (en) Peptides
EP2093227A4 (fr) Complexe polynucléaire
TWM300304U (en) Light-increasing-diffusing structure
GB0617223D0 (en) Complex
GB0625861D0 (en) Modified flexicast/flexisplint
GB0622348D0 (en) Retaining means
GB0617387D0 (en) Synthetic gene
GB0614682D0 (en) Proteins